PLATINUM

PLATINUM was reported 531 times

PLATINUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUROENDOCRINE CARCINOMA OF THE CERVIX 2 0.1333
1 MALIGNANT URINARY TRACT OBSTRUCTION 1 0.1250
2 NASOPHARYNGEAL CANCER METASTATIC 1 0.0909
3 LUNG ADENOCARCINOMA STAGE 0 1 0.0909
4 SALIVARY DUCT INFLAMMATION 1 0.0435
5 HEPATITIS B CORE ANTIBODY POSITIVE 15 0.0398
6 OSTEOSARCOMA RECURRENT 2 0.0333
7 GROWING TERATOMA SYNDROME 1 0.0303
8 RENAL ARTERIOSCLEROSIS 5 0.0205
9 TERATOMA BENIGN 1 0.0185
10 IMMUNE-MEDIATED PERICARDITIS 1 0.0182
11 ESCHERICHIA PERITONITIS 1 0.0182
12 REACTIVE CAPILLARY ENDOTHELIAL PROLIFERATION 1 0.0182
13 TUMOUR INFLAMMATION 2 0.0179
14 PCO2 ABNORMAL 1 0.0172
15 WHITE BLOOD CELL ANALYSIS ABNORMAL 1 0.0161
16 IMMUNE-MEDIATED PNEUMONITIS 3 0.0128
17 CHORIOCARCINOMA 1 0.0127
18 BONE MARROW LEUKAEMIC CELL INFILTRATION 1 0.0122
19 LUNG ADENOCARCINOMA RECURRENT 1 0.0097
20 VASCULITIS GASTROINTESTINAL 1 0.0091
21 SMALL CELL LUNG CANCER EXTENSIVE STAGE 1 0.0087
22 LUMBAR PUNCTURE ABNORMAL 1 0.0086
23 LACRIMATION DISORDER 1 0.0082
24 PANCREATIC ENZYMES DECREASED 1 0.0078
25 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL 1 0.0075
26 MEDICAL DEVICE SITE REACTION 1 0.0063
27 CERVIX CANCER METASTATIC 1 0.0061
28 HYPERBARIC OXYGEN THERAPY 1 0.0060
29 PLASMA CELL MYELOMA REFRACTORY 8 0.0060
30 EYELID BLEEDING 1 0.0058
31 RIGHT VENTRICULAR HYPERTROPHY 5 0.0055
32 METASTASES TO MUSCLE 1 0.0055
33 LARYNGEAL INFLAMMATION 1 0.0053
34 RADIATION OESOPHAGITIS 2 0.0052
35 LUNG ADENOCARCINOMA STAGE IV 2 0.0052
36 OVARIAN EPITHELIAL CANCER 1 0.0052
37 ADENOCARCINOMA METASTATIC 1 0.0049
38 PNEUMOCONIOSIS 1 0.0048
39 VOCAL CORD PARESIS 1 0.0043
40 DENTAL TREATMENT 1 0.0041
41 METABOLIC DISORDER 24 0.0041
42 PULMONARY RESECTION 1 0.0040
43 TROPONIN T INCREASED 5 0.0039
44 IMMUNE-MEDIATED HYPERTHYROIDISM 1 0.0039
45 INFESTATION 1 0.0039
46 VANISHING BILE DUCT SYNDROME 4 0.0036
47 IMMUNE-MEDIATED HEPATITIS 7 0.0034
48 PRIMARY ADRENAL INSUFFICIENCY 1 0.0033
49 HEPATITIS ALCOHOLIC 1 0.0031
50 SMALL CELL CARCINOMA 1 0.0029
51 WOUND ABSCESS 1 0.0029
52 SMALL CELL LUNG CANCER METASTATIC 1 0.0028
53 ARTERIAL INJURY 2 0.0027
54 ALKALOSIS 1 0.0026
55 IMMUNE-MEDIATED ADVERSE REACTION 4 0.0026
56 GASTROINTESTINAL ANASTOMOTIC LEAK 1 0.0026
57 CATHETER SITE EXTRAVASATION 1 0.0025
58 SKIN CHAPPED 1 0.0025
59 PULMONARY CALCIFICATION 1 0.0024
60 IMMUNE-MEDIATED RENAL DISORDER 1 0.0024
61 NON-SMALL CELL LUNG CANCER METASTATIC 2 0.0023
62 IMMUNE-MEDIATED HYPOPHYSITIS 1 0.0022
63 URETHRAL DISORDER 1 0.0021
64 TUMOUR NECROSIS 2 0.0019
65 NEPHRITIS 6 0.0018
66 TUMOUR RUPTURE 1 0.0018
67 IMMUNE-MEDIATED HYPOTHYROIDISM 2 0.0018
68 METAL POISONING 1 0.0017
69 LYMPHATIC DISORDER 1 0.0017
70 RENAL TUBULAR INJURY 2 0.0016
71 PULMONARY TUBERCULOSIS 7 0.0016
72 HEPATOBILIARY DISEASE 1 0.0016
73 PNEUMONIA NECROTISING 1 0.0015
74 REFLEXES ABNORMAL 1 0.0015
75 ACQUIRED GENE MUTATION 2 0.0015
76 HYPOPHYSITIS 3 0.0015
77 VITAMIN B12 DEFICIENCY 6 0.0015
78 CYTOKINE STORM 1 0.0015
79 NEUROENDOCRINE CARCINOMA 1 0.0014
80 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
81 BLOOD ELECTROLYTES DECREASED 2 0.0014
82 SPONTANEOUS HAEMATOMA 1 0.0013
83 PROTEIN TOTAL DECREASED 5 0.0013
84 OVARIAN CANCER 12 0.0013
85 ESCHERICHIA BACTERAEMIA 3 0.0013
86 BLOOD LACTATE DEHYDROGENASE INCREASED 20 0.0013
87 OPTIC ATROPHY 2 0.0012
88 SECOND PRIMARY MALIGNANCY 10 0.0012
89 AMAUROSIS 1 0.0012
90 CARBOHYDRATE ANTIGEN 125 INCREASED 4 0.0012
91 PERIPHERAL NERVE INJURY 1 0.0011
92 MYOCARDITIS 13 0.0011
93 BLOOD SODIUM INCREASED 3 0.0011
94 BONE LESION 4 0.0011
95 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
96 METASTASES TO ADRENALS 1 0.0011
97 PLASMACYTOMA 2 0.0011
98 NON-SMALL CELL LUNG CANCER 5 0.0010
99 APPLICATION SITE BRUISE 1 0.0010
100 IMMUNE-MEDIATED HEPATIC DISORDER 2 0.0010
101 RADIATION PNEUMONITIS 2 0.0009
102 PNEUMONITIS 25 0.0009
103 TUMOUR PSEUDOPROGRESSION 1 0.0009
104 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 2 0.0009
105 ADENOCARCINOMA 2 0.0009
106 ARTERIAL HAEMORRHAGE 1 0.0009
107 BLOOD URIC ACID INCREASED 5 0.0009
108 HYPOCHLORAEMIA 1 0.0009
109 ACUTE LUNG INJURY 1 0.0008
110 THERAPY PARTIAL RESPONDER 13 0.0008
111 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
112 BLOOD CALCIUM DECREASED 9 0.0008
113 HEPATITIS TOXIC 2 0.0008
114 AREFLEXIA 2 0.0007
115 BRONCHIAL OBSTRUCTION 1 0.0007
116 ALVEOLITIS 1 0.0007
117 SKIN TOXICITY 4 0.0007
118 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
119 TONIC CONVULSION 1 0.0007
120 MYELODYSPLASTIC SYNDROME 10 0.0007
121 CHOLANGIOCARCINOMA 1 0.0007
122 DRUG RESISTANCE 17 0.0007
123 EMBOLISM VENOUS 2 0.0007
124 INFECTIOUS PLEURAL EFFUSION 1 0.0007
125 BLOOD ALBUMIN DECREASED 5 0.0006
126 HEPATITIS B REACTIVATION 2 0.0006
127 TRICUSPID VALVE INCOMPETENCE 5 0.0006
128 OVARIAN CANCER RECURRENT 1 0.0006
129 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
130 PLASMA CELL MYELOMA RECURRENT 2 0.0006
131 RENAL TUBULAR NECROSIS 6 0.0006
132 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
133 PHLEBITIS 3 0.0006
134 FEMALE GENITAL TRACT FISTULA 1 0.0006
135 HEPATOTOXICITY 13 0.0006
136 BLOOD CREATININE ABNORMAL 2 0.0006
137 EXTREMITY NECROSIS 1 0.0006
138 MONOPARESIS 1 0.0006
139 OTOTOXICITY 1 0.0005
140 PUPILLARY REFLEX IMPAIRED 1 0.0005
141 MUCOSAL INFLAMMATION 14 0.0005
142 DISEASE PROGRESSION 63 0.0005
143 ARTERIOSCLEROSIS 5 0.0005
144 HAEMATOTOXICITY 5 0.0005
145 METASTASES TO LUNG 6 0.0005
146 ARTERIAL THROMBOSIS 1 0.0005
147 TRAUMATIC LUNG INJURY 1 0.0005
148 APLASIA 1 0.0005
149 ABNORMAL FAECES 4 0.0005
150 QUADRIPLEGIA 1 0.0005
151 CAPILLARY LEAK SYNDROME 1 0.0005
152 GASTROINTESTINAL PERFORATION 2 0.0005
153 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
154 PROTEINURIA 9 0.0005
155 ENDOMETRIAL CANCER 1 0.0005
156 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
157 NEUROLOGICAL DECOMPENSATION 1 0.0004
158 MALIGNANT NEOPLASM PROGRESSION 44 0.0004
159 URINARY TRACT OBSTRUCTION 1 0.0004
160 HEART INJURY 1 0.0004
161 PHYSICAL DECONDITIONING 1 0.0004
162 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
163 BONE DISORDER 7 0.0004
164 WEIGHT FLUCTUATION 4 0.0004
165 NASAL DISORDER 1 0.0004
166 POLYURIA 3 0.0004
167 SUBDURAL HAEMORRHAGE 1 0.0004
168 PULMONARY FIBROSIS 7 0.0004
169 CHOLECYSTITIS INFECTIVE 1 0.0004
170 ANAL HAEMORRHAGE 1 0.0004
171 NEPHROPATHY TOXIC 4 0.0004
172 RENAL TUBULAR DISORDER 1 0.0004
173 NEUTROPHIL COUNT ABNORMAL 1 0.0004
174 HEPATITIS 9 0.0004
175 OESOPHAGEAL STENOSIS 1 0.0004
176 BLOOD MAGNESIUM DECREASED 3 0.0003
177 PERICARDIAL EFFUSION 8 0.0003
178 BONE MARROW FAILURE 7 0.0003
179 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
180 FEBRILE NEUTROPENIA 22 0.0003
181 ADRENAL INSUFFICIENCY 4 0.0003
182 LIVER FUNCTION TEST INCREASED 7 0.0003
183 BLOOD CREATININE DECREASED 1 0.0003
184 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
185 THROMBOSIS IN DEVICE 1 0.0003
186 METASTASES TO BONE 5 0.0003
187 THROMBOCYTOPENIA 34 0.0003
188 OTITIS MEDIA 1 0.0003
189 APPETITE DISORDER 2 0.0003
190 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
191 BLOOD UREA INCREASED 5 0.0003
192 BRONCHIECTASIS 2 0.0003
193 HEPATIC FIBROSIS 1 0.0003
194 ENCEPHALITIS 2 0.0003
195 MYELOSUPPRESSION 10 0.0003
196 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
197 AMYLASE INCREASED 1 0.0003
198 RETINOPATHY 1 0.0003
199 CATHETER SITE INFECTION 1 0.0003
200 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
201 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
202 PLASMA CELL MYELOMA 10 0.0003
203 HAEMORRHAGIC STROKE 2 0.0003
204 EPIGASTRIC DISCOMFORT 1 0.0003
205 CEREBRAL ATROPHY 1 0.0003
206 HYPOTHYROIDISM 8 0.0003
207 NEUTROPENIA 34 0.0002
208 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
209 MUSCLE HAEMORRHAGE 1 0.0002
210 TRIGEMINAL NEURALGIA 1 0.0002
211 ORGAN FAILURE 1 0.0002
212 BLOOD POTASSIUM INCREASED 4 0.0002
213 APPLICATION SITE DISCOLOURATION 1 0.0002
214 NEUTROPHIL COUNT DECREASED 10 0.0002
215 RECURRENT CANCER 1 0.0002
216 PERIPHERAL ISCHAEMIA 1 0.0002
217 DEMYELINATION 1 0.0002
218 BRAIN OEDEMA 3 0.0002
219 ANAPHYLACTIC SHOCK 6 0.0002
220 METASTATIC NEOPLASM 1 0.0002
221 PYELONEPHRITIS 2 0.0002
222 URINE OUTPUT DECREASED 2 0.0002
223 BEDRIDDEN 3 0.0002
224 METASTASES TO LIVER 4 0.0002
225 LUNG INFILTRATION 2 0.0002
226 BLOOD CREATINE INCREASED 1 0.0002
227 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
228 TRANSAMINASES INCREASED 5 0.0002
229 CARDIOTOXICITY 2 0.0002
230 HAEMOGLOBIN INCREASED 1 0.0002
231 UROSEPSIS 2 0.0002
232 HEPATOCELLULAR INJURY 3 0.0002
233 ACUTE RESPIRATORY FAILURE 4 0.0002
234 HYPERTHYROIDISM 3 0.0002
235 ENTEROCOCCAL INFECTION 1 0.0002
236 GUILLAIN-BARRE SYNDROME 1 0.0002
237 MUCOUS STOOLS 1 0.0002
238 ORGANISING PNEUMONIA 1 0.0002
239 VEIN DISORDER 1 0.0002
240 EMPHYSEMA 2 0.0002
241 VARICOSE VEIN 1 0.0002
242 ACUTE MYELOID LEUKAEMIA 3 0.0002
243 DERMATITIS 4 0.0002
244 PNEUMOTHORAX 3 0.0002
245 SUDDEN DEATH 2 0.0002
246 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
247 COLITIS 7 0.0002
248 BLOOD CREATININE INCREASED 12 0.0002
249 HYDROCEPHALUS 1 0.0002
250 FISTULA 2 0.0002
251 CHOLECYSTITIS ACUTE 1 0.0002
252 MYOCARDIAL ISCHAEMIA 2 0.0002
253 ANAEMIA 33 0.0002
254 NEOPLASM PROGRESSION 6 0.0002
255 ELECTROLYTE IMBALANCE 2 0.0002
256 VASCULITIS 2 0.0002
257 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
258 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
259 PLEURISY 1 0.0002
260 NEUROPATHY PERIPHERAL 16 0.0002
261 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
262 PLATELET COUNT ABNORMAL 1 0.0002
263 DERMATITIS ACNEIFORM 1 0.0002
264 ENCEPHALOPATHY 4 0.0002
265 OLIGURIA 1 0.0002
266 HAEMOGLOBIN ABNORMAL 1 0.0002
267 HYPOGAMMAGLOBULINAEMIA 1 0.0002
268 CORONAVIRUS INFECTION 1 0.0002
269 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
270 TERMINAL STATE 1 0.0001
271 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
272 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
273 STOMATITIS 9 0.0001
274 METASTASES TO LYMPH NODES 1 0.0001
275 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
276 NEPHROTIC SYNDROME 1 0.0001
277 RESPIRATION ABNORMAL 1 0.0001
278 LARGE INTESTINE PERFORATION 1 0.0001
279 PANCYTOPENIA 8 0.0001
280 PULMONARY TOXICITY 1 0.0001
281 RETINAL HAEMORRHAGE 1 0.0001
282 METASTASIS 1 0.0001
283 PANIC REACTION 1 0.0001
284 HEPATIC FUNCTION ABNORMAL 5 0.0001
285 HYDRONEPHROSIS 1 0.0001
286 THERAPY NON-RESPONDER 6 0.0001
287 PLEURAL EFFUSION 8 0.0001
288 RENAL FAILURE CHRONIC 1 0.0001
289 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
290 LYMPHOMA 2 0.0001
291 EJECTION FRACTION DECREASED 2 0.0001
292 HYPOALBUMINAEMIA 1 0.0001
293 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
294 ATRIAL FLUTTER 1 0.0001
295 MIOSIS 1 0.0001
296 SENSORY LOSS 1 0.0001
297 RHINITIS 1 0.0001
298 MYASTHENIA GRAVIS 1 0.0001
299 SPINAL COMPRESSION FRACTURE 1 0.0001
300 EMBOLISM 1 0.0001
301 LEUKOPENIA 6 0.0001
302 CANDIDA INFECTION 2 0.0001
303 PULMONARY EMBOLISM 11 0.0001
304 NEUROTOXICITY 2 0.0001
305 HYPOXIA 4 0.0001
306 LYMPHOCYTE COUNT DECREASED 2 0.0001
307 RESPIRATORY RATE INCREASED 1 0.0001
308 MYOSITIS 1 0.0001
309 LOSS OF LIBIDO 1 0.0001
310 OPTIC NEURITIS 1 0.0001
311 PNEUMONIA BACTERIAL 1 0.0001
312 ERYTHEMA MULTIFORME 1 0.0001
313 HEPATIC ENCEPHALOPATHY 1 0.0001
314 NEPHROPATHY 1 0.0001
315 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
316 INTESTINAL OBSTRUCTION 4 0.0001
317 LEUKAEMIA 1 0.0001
318 FLATULENCE 6 0.0001
319 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
320 PLATELET COUNT DECREASED 11 0.0001
321 DIZZINESS POSTURAL 1 0.0001
322 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
323 ASCITES 3 0.0001
324 RENAL INJURY 3 0.0001
325 LACRIMATION INCREASED 3 0.0001
326 ACUTE KIDNEY INJURY 15 0.0001
327 EAR DISCOMFORT 1 0.0001
328 LUNG NEOPLASM MALIGNANT 4 0.0001
329 POOR VENOUS ACCESS 1 0.0001
330 HYPERBILIRUBINAEMIA 1 0.0001
331 NERVOUS SYSTEM DISORDER 3 0.0001
332 BREAST CANCER METASTATIC 1 0.0001
333 OESOPHAGITIS 1 0.0001
334 ASPIRATION 1 0.0001
335 GASTROINTESTINAL PAIN 1 0.0001
336 STEVENS-JOHNSON SYNDROME 2 0.0001
337 HYPERTENSION 19 0.0001
338 SKIN INFECTION 1 0.0001
339 INTESTINAL PERFORATION 1 0.0001
340 HYPONATRAEMIA 5 0.0001
341 NEOPLASM 1 0.0001
342 HYPOKALAEMIA 4 0.0001
343 POLYNEUROPATHY 1 0.0001
344 RENAL IMPAIRMENT 7 0.0001
345 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
346 CEREBRAL INFARCTION 2 0.0001
347 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
348 MUSCLE ATROPHY 1 0.0001
349 CARDIOVASCULAR DISORDER 2 0.0001
350 ERECTILE DYSFUNCTION 2 0.0001
351 GENITAL HAEMORRHAGE 1 0.0001
352 DECREASED APPETITE 18 0.0001
353 ECZEMA 4 0.0001
354 IMMUNE SYSTEM DISORDER 1 0.0001
355 BLOOD BILIRUBIN INCREASED 2 0.0001
356 UVEITIS 1 0.0001
357 DRUG TOXICITY 1 0.0001
358 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
359 HAEMATOCHEZIA 4 0.0001
360 HYPOMAGNESAEMIA 1 0.0001
361 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
362 LYMPHOPENIA 1 0.0001
363 SEASONAL ALLERGY 1 0.0001
364 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
365 SUBDURAL HAEMATOMA 1 0.0001
366 IMPAIRED QUALITY OF LIFE 1 0.0001
367 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
368 CONSTIPATION 15 0.0001
369 LIVER FUNCTION TEST ABNORMAL 2 0.0001
370 RENAL FAILURE 9 0.0001
371 TACHYCARDIA 6 0.0001
372 PULMONARY MASS 1 0.0001
373 TINNITUS 3 0.0001
374 ADVERSE EVENT 6 0.0001
375 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
376 TENDONITIS 1 0.0001
377 ULCER 1 0.0001
378 ABSCESS 1 0.0001
379 PHOTOSENSITIVITY REACTION 1 0.0001
380 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
381 SKIN DISORDER 2 0.0001
382 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
383 HEPATIC ENZYME INCREASED 4 0.0001
384 GOUT 1 0.0001
385 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
386 OSTEOMYELITIS 1 0.0001
387 HYPERGLYCAEMIA 2 0.0001
388 DYSARTHRIA 2 0.0001
389 BLOOD SODIUM DECREASED 1 0.0001
390 HYPOCALCAEMIA 1 0.0001
391 FOOT FRACTURE 1 0.0001
392 GASTRIC ULCER 1 0.0001
393 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
394 INCREASED APPETITE 1 0.0001
395 CHOLESTASIS 1 0.0001
396 OFF LABEL USE 45 0.0001
397 CYTOKINE RELEASE SYNDROME 1 0.0000
398 PRODUCT ADMINISTRATION ERROR 1 0.0000
399 FEEDING DISORDER 1 0.0000
400 TASTE DISORDER 1 0.0000
401 CHEST DISCOMFORT 5 0.0000
402 FATIGUE 38 0.0000
403 RIB FRACTURE 1 0.0000
404 PERITONITIS 1 0.0000
405 ASTHENIA 18 0.0000
406 HAEMORRHAGE 5 0.0000
407 MOUTH ULCERATION 1 0.0000
408 EATING DISORDER 1 0.0000
409 VOMITING 22 0.0000
410 HYPOACUSIS 2 0.0000
411 FAECES DISCOLOURED 1 0.0000
412 CONDITION AGGRAVATED 14 0.0000
413 DEVICE DISLOCATION 2 0.0000
414 SEPTIC SHOCK 2 0.0000
415 MELAENA 1 0.0000
416 APPLICATION SITE PAIN 1 0.0000
417 ANGIOEDEMA 2 0.0000
418 ORAL PAIN 1 0.0000
419 RASH PAPULAR 1 0.0000
420 PANCREATITIS ACUTE 1 0.0000
421 PNEUMONIA 14 0.0000
422 RENAL DISORDER 2 0.0000
423 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
424 DYSPHAGIA 4 0.0000
425 INTERSTITIAL LUNG DISEASE 2 0.0000
426 MENTAL IMPAIRMENT 1 0.0000
427 RESPIRATORY FAILURE 3 0.0000
428 LIVER INJURY 1 0.0000
429 HALLUCINATION 3 0.0000
430 CELLULITIS 2 0.0000
431 COUGH 11 0.0000
432 HOSPITALISATION 6 0.0000
433 DIARRHOEA 25 0.0000
434 SKIN ULCER 1 0.0000
435 RESPIRATORY TRACT INFECTION 1 0.0000
436 DEATH 33 0.0000
437 DEAFNESS 1 0.0000
438 PANCREATITIS 2 0.0000
439 JAUNDICE 1 0.0000
440 OEDEMA 2 0.0000
441 SKIN LESION 1 0.0000
442 ANAPHYLACTIC REACTION 2 0.0000
443 SEPSIS 4 0.0000
444 HAEMOPTYSIS 1 0.0000
445 BLISTER 2 0.0000
446 OXYGEN SATURATION DECREASED 2 0.0000
447 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
448 RED BLOOD CELL COUNT DECREASED 1 0.0000
449 RASH 15 0.0000
450 ACUTE MYOCARDIAL INFARCTION 1 0.0000
451 HEPATIC FAILURE 1 0.0000
452 ILL-DEFINED DISORDER 2 0.0000
453 DRUG-INDUCED LIVER INJURY 1 0.0000
454 PYREXIA 11 0.0000
455 DRUG INTOLERANCE 3 0.0000
456 ATRIAL FIBRILLATION 3 0.0000
457 DEEP VEIN THROMBOSIS 2 0.0000
458 CHOLELITHIASIS 1 0.0000
459 IMPAIRED HEALING 1 0.0000
460 OSTEONECROSIS 1 0.0000
461 NAUSEA 24 0.0000
462 TOXICITY TO VARIOUS AGENTS 5 0.0000
463 HAEMOGLOBIN DECREASED 3 0.0000
464 HAEMATURIA 1 0.0000
465 ABDOMINAL DISTENSION 3 0.0000
466 WEIGHT DECREASED 8 0.0000
467 HYPERKALAEMIA 1 0.0000
468 LYMPHADENOPATHY 1 0.0000
469 MOBILITY DECREASED 2 0.0000
470 INFECTION 4 0.0000
471 RESTLESSNESS 1 0.0000
472 DYSURIA 1 0.0000
473 CHEST PAIN 5 0.0000
474 EPISTAXIS 2 0.0000
475 DYSPNOEA EXERTIONAL 1 0.0000
476 MUSCULAR WEAKNESS 3 0.0000
477 SEIZURE 3 0.0000
478 HYPOTENSION 5 0.0000
479 THROMBOSIS 2 0.0000
480 DYSPNOEA 14 0.0000
481 DRY MOUTH 2 0.0000
482 OEDEMA PERIPHERAL 3 0.0000
483 BLINDNESS 1 0.0000
484 OSTEOPOROSIS 1 0.0000
485 OSTEOARTHRITIS 1 0.0000
486 RENAL FAILURE ACUTE 1 0.0000
487 DEVICE LEAKAGE 1 0.0000
488 VAGINAL HAEMORRHAGE 1 0.0000
489 COVID-19 4 0.0000
490 LIVER DISORDER 1 0.0000
491 PULMONARY OEDEMA 1 0.0000
492 WEIGHT INCREASED 5 0.0000
493 GASTROINTESTINAL DISORDER 2 0.0000
494 ADVERSE DRUG REACTION 2 0.0000
495 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
496 COGNITIVE DISORDER 1 0.0000
497 PAIN 13 0.0000
498 DISEASE RECURRENCE 1 0.0000
499 COMA 1 0.0000
500 GAIT DISTURBANCE 4 0.0000
501 DRY EYE 1 0.0000
502 MUSCULOSKELETAL PAIN 1 0.0000
503 SPEECH DISORDER 1 0.0000
504 PARAESTHESIA 3 0.0000
505 INSOMNIA 5 0.0000
506 CONFUSIONAL STATE 3 0.0000
507 INFLUENZA 2 0.0000
508 LETHARGY 1 0.0000
509 EYE IRRITATION 1 0.0000
510 ABDOMINAL PAIN 4 0.0000
511 DYSPHONIA 1 0.0000
512 CHILLS 2 0.0000
513 PAIN IN EXTREMITY 5 0.0000
514 CATARACT 1 0.0000
515 THERAPEUTIC RESPONSE DECREASED 1 0.0000
516 VERTIGO 1 0.0000
517 DISCOMFORT 1 0.0000
518 MALAISE 7 0.0000
519 INFUSION RELATED REACTION 1 0.0000
520 DEHYDRATION 2 0.0000
521 SOMNOLENCE 3 0.0000
522 DRUG INEFFECTIVE 19 0.0000
523 BURNING SENSATION 1 0.0000
524 UNDERDOSE 1 0.0000
525 BRONCHITIS 1 0.0000
526 DYSGEUSIA 1 0.0000
527 UNEVALUABLE EVENT 1 0.0000
528 DIABETES MELLITUS 1 0.0000
529 DRUG DOSE OMISSION BY DEVICE 1 0.0000
530 DRUG INTERACTION 2 0.0000
531 CARDIAC FAILURE 1 0.0000
532 CARDIAC FAILURE CONGESTIVE 1 0.0000
533 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
534 MYALGIA 2 0.0000
535 URINARY TRACT INFECTION 2 0.0000
536 MYOCARDIAL INFARCTION 2 0.0000
537 DEVICE ISSUE 1 0.0000
538 MUSCLE SPASMS 2 0.0000
539 HYPERSENSITIVITY 2 0.0000
540 SWELLING 1 0.0000
541 PRODUCT USE ISSUE 2 0.0000
542 PRURITUS 4 0.0000
543 ALOPECIA 2 0.0000
544 HEART RATE INCREASED 1 0.0000
545 DIZZINESS 5 0.0000
546 SYNCOPE 1 0.0000
547 ABDOMINAL PAIN UPPER 2 0.0000
548 ARTHRALGIA 4 0.0000
549 BACK PAIN 2 0.0000
550 PSORIASIS 1 0.0000
551 MEMORY IMPAIRMENT 1 0.0000
552 PERIPHERAL SWELLING 1 0.0000
553 CEREBROVASCULAR ACCIDENT 1 0.0000
554 BLOOD GLUCOSE INCREASED 1 0.0000
555 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
556 ERYTHEMA 1 0.0000
557 HEADACHE 3 0.0000
558 OVERDOSE 1 0.0000
559 INCORRECT DOSE ADMINISTERED 1 0.0000
560 FEELING ABNORMAL 1 0.0000
561 ANXIETY 1 0.0000
562 PRODUCT DOSE OMISSION ISSUE 1 0.0000
563 FALL 1 0.0000